A lawsuit was filed on behalf of investors in Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) shares over alleged securities laws violations.

San Diego, CA -- (SBWire) -- 06/26/2017 --An investor in shares of Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) filed a lawsuit over alleged violations Securities Laws by Roche Holding Ltd.

Investors who purchased shares of Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) have certain options and for certain investors are short and strict deadlines running. Deadline: August 7, 2017. Roche Holding Ltd. (ADR) investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The plaintiff claims that between March 2, 2017 and June 5, 2017 the defendants made false and/or misleading statements and/or failed to disclose that the combination of Perjeta and Herceptin is only marginally more effective than Herceptin alone in preventing breast cancer, and that as a result, Defendants' statements about Roche's business, operations and prospects were materially false and misleading and/or lacked a reasonable bases at all relevant times.

Switzerland based Roche Holding AG (Roche) is a research-based healthcare company. Roche Holding Ltd. reported that its annual Total Revenue rose from over 48.14 billion CHF in 2015 to over 50.57 billion CHF in 2016 and that its Net income increased from over 8.86 billion CHF in 2015 to over 9.57 billion CHF in 2016. Shares of Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) grew from $27.08 per share in December 2016 to $34.67 per share on May 22, 2017.

On June 5, 2017, news outlets reported that a new study showed that adding Roche's breast cancer drug Perjeta to the company's older treatment Herceptin only conferred a slight benefit while more than doubling the one-year treatment cost. The study also found that the combination of Perjeta with Herceptin also had higher rates of certain side effects than Herceptin alone, including severe diarrhea. Shares of Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) declined to as low as $31.59 per share on June 5, 2017.

On June 23, 2017, OTCMKTS:RHHBY shares closed at $32.76 per share.

Those who purchased shares of Roche Holding Ltd. (ADR) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com